Phase II Study of Avelumab in Multiple Relapsed/Refractory Testicular Germ Cell Cancer.
Phase of Trial: Phase II
Latest Information Update: 30 Jan 2018
At a glance
- Drugs Avelumab (Primary)
- Indications Germ cell and embryonal neoplasms; Seminoma; Testicular cancer
- Focus Proof of concept; Therapeutic Use
- 23 Jan 2018 New trial record